[HTML][HTML] Treatment of hyperprolactinemia: a systematic review and meta-analysis
AT Wang, RJ Mullan, MA Lane, A Hazem, C Prasad… - Systematic reviews, 2012 - Springer
Background Hyperprolactinemia is a common endocrine disorder that can be associated
with significant morbidity. We conducted a systematic review and meta-analyses of …
with significant morbidity. We conducted a systematic review and meta-analyses of …
Treatment of hyperprolactinemia: a systematic review and meta-analysis.
AT Wang, RJ Mullan, MA Lane, A Hazem… - Systematic …, 2012 - europepmc.org
Background Hyperprolactinemia is a common endocrine disorder that can be associated
with significant morbidity. We conducted a systematic review and meta-analyses of …
with significant morbidity. We conducted a systematic review and meta-analyses of …
Treatment of hyperprolactinemia: a systematic review and meta-analysis
AT Wang, RJ Mullan, MA Lane, A Hazem… - Systematic …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Hyperprolactinemia is a common endocrine disorder that can be associated
with significant morbidity. We conducted a systematic review and meta-analyses of …
with significant morbidity. We conducted a systematic review and meta-analyses of …
[HTML][HTML] Treatment of hyperprolactinemia: a systematic review and meta-analysis
AT Wang, RJ Mullan, MA Lane, A Hazem… - Systematic …, 2012 - ncbi.nlm.nih.gov
Background Hyperprolactinemia is a common endocrine disorder that can be associated
with significant morbidity. We conducted a systematic review and meta-analyses of …
with significant morbidity. We conducted a systematic review and meta-analyses of …
[HTML][HTML] Treatment of hyperprolactinemia: a systematic review and meta-analysis
AT Wang, RJ Mullan, MA Lane… - Systematic …, 2012 - systematicreviewsjournal …
Hyperprolactinemia is a common endocrine disorder that can be associated with significant
morbidity. We conducted a systematic review and meta-analyses of outcomes of …
morbidity. We conducted a systematic review and meta-analyses of outcomes of …
[PDF][PDF] Treatment of hyperprolactinemia: a systematic review and meta-analysis
AT Wang, RJ Mullan, MA Lane, A Hazem, C Prasad… - 2012 - cyberleninka.org
Background: Hyperprolactinemia is a common endocrine disorder that can be associated
with significant morbidity. We conducted a systematic review and meta-analyses of …
with significant morbidity. We conducted a systematic review and meta-analyses of …
Treatment of hyperprolactinemia: A systematic review and meta-analysis
AT Wang, RJ Mullan, MA Lane… - Systematic …, 2006 - mayoclinic.elsevierpure.com
Background: Hyperprolactinemia is a common endocrine disorder that can be associated
with significant morbidity. We conducted a systematic review and meta-analyses of …
with significant morbidity. We conducted a systematic review and meta-analyses of …
[PDF][PDF] Treatment of hyperprolactinemia: a systematic review and meta-analysis
AT Wang, RJ Mullan, MA Lane, A Hazem, C Prasad… - 2012 - Citeseer
Background: Hyperprolactinemia is a common endocrine disorder that can be associated
with significant morbidity. We conducted a systematic review and meta-analyses of …
with significant morbidity. We conducted a systematic review and meta-analyses of …
[PDF][PDF] Treatment of hyperprolactinemia: a systematic review and meta-analysis
AT Wang, RJ Mullan, MA Lane, A Hazem, C Prasad… - 2012 - researchgate.net
Background: Hyperprolactinemia is a common endocrine disorder that can be associated
with significant morbidity. We conducted a systematic review and meta-analyses of …
with significant morbidity. We conducted a systematic review and meta-analyses of …
Treatment of hyperprolactinemia: a systematic review and meta-analysis
AT Wang, RJ Mullan, MA Lane, A Hazem… - Systematic …, 2012 - go.gale.com
Background Hyperprolactinemia is a common endocrine disorder that can be associated
with significant morbidity. We conducted a systematic review and meta-analyses of …
with significant morbidity. We conducted a systematic review and meta-analyses of …